Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Pulmonary Vascular Disease
•
Hospital Medicine
What patient related factors and hemodynamic parameters would lead you to avoid transbronchial biopsies in patients with pulmonary hypertension?
Answer from: at Community Practice
I try to avoid if INR is > 1.7 or platelet count is less than 30,000 in patients who have Grp I PAH.
Sign In
or
Register
to read more
14421
Related Questions
Are you more permissive of perioperative interruption of anticoagulation for VTE depending on the location and relative chronicity of the thrombus?
What are your thoughts on trending beta-hydroxybutyrate once a diagnosis of DKA is already established?
Do you routinely use systemic corticosteroids for treatment of fat embolism in patients who are hemodynamically stable?
What do you think about using conventional thoracic imaging methods (e.g., X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?
What is your approach to volume resuscitation in patients who are third spacing fluids?
What is the goal oxygen saturation for patients with COPD and pulmonary hypertension?
How do you decide which IV opioid to use for symptom relief at the end of life?
When can we consider deferring an insulin drip in patients with hypertriglyceridemia-induced pancreatitis?
What are some practical tips for when a patient's consistently stated goals of care do not correlate with their actions?
How do you plan to integrate sotatercept into the current treatment algorithm for PAH, particularly in patients who are stable on existing therapies?